Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., et al. (1997) · Science · doi:10.1126/science.278.5341.1295 · Cited by 3,098 · see citing works

A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

Hammer, S. M., Squires, K., Hughes, M. D., Grimes, J. M., Demeter, L. M., Currier, J. S., Eron, J. J., Feinberg, J., Balfour, H. H., Deyton, L., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371101 · Cited by 2,638 · see citing works

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

Wong, J. K., Hezareh, M., Günthard, H. F., Havlir, D. V., Ignacio, C. C., Spina, C. A., & Richman, D. D. (1997) · Science · doi:10.1126/science.278.5341.1291 · Cited by 2,186 · see citing works

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

Finzi, D., Blankson, J., Siliciano, J. D., Margolick, J. B., Chadwick, K., Pierson, T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., et al. (1999) · Nature Medicine · doi:10.1038/8394 · Cited by 2,119 · see citing works

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

Chun, T.-W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J. A., Taylor, H., Hermankova, M., Chadwick, K., Margolick, J., Quinn, T. C., et al. (1997) · Nature · doi:10.1038/387183a0 · Cited by 2,050 · see citing works

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

Chun, T., Stuyver, L. J., Mizell, S. B., Ehler, L. A., Mican, J. A. M., Baseler, M., Lloyd, A. L., Nowak, M. A., & Fauci, A. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13193 · Cited by 1,960 · see citing works

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

Gulick, R. M., Mellors, J. W., Havlir, D. V., Eron, J. J., Gonzalez, C. J., McMahon, D. K., Richman, D. D., Valentine, F. T., Jonas, L., Meibohm, A. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371102 · Cited by 1,883 · see citing works

Decay characteristics of HIV-1-infected compartments during combination therapy

Perelson, A. S., Essunger, P., Cao, Y., Vesanen, M., Hurley, A., Saksela, K., Markowitz, M. H., & Ho, D. D. (1997) · Nature · doi:10.1038/387188a0 · Cited by 1,861 · see citing works

Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral Therapy

Zhang, L., Ramratnam, B., Tenner‐Racz, K., He, Y., Vesanen, M., Lewin, S. R., Talal, A. H., Rácz, P., Perelson, A. S., Korber, B., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905273402101 · Cited by 797 · see citing works

In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency

Chun, T., Finzi, D., Margolick, J. B., Chadwick, K. R., Schwartz, D. H., & Siliciano, R. F. (1995) · Nature Medicine · doi:10.1038/nm1295-1284 · Cited by 787 · see citing works

The Challenge of Viral Reservoirs in HIV-1 Infection

Blankson, J. N., Persaud, D., & Siliciano, R. F. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104024 · Cited by 623 · see citing works

Residual HIV-1 RNA in Blood Plasma of Patients Taking Suppressive Highly Active Antiretroviral Therapy

Dornadula, G. (1999) · JAMA · doi:10.1001/jama.282.17.1627 · Cited by 466 · see citing works

The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy

Ramratnam, B., Mittler, J. E., Zhang, L., Boden, D., Hurley, A., Fang, F., Macken, C. A., Perelson, A. S., Markowitz, M. H., & Ho, D. D. (2000) · Nature Medicine · doi:10.1038/71577 · Cited by 448 · see citing works

HIV-1 Drug Resistance Profiles in Children and Adults With Viral Load of <50 Copies/mL Receiving Combination Therapy

Hermankova, M. (2001) · JAMA · doi:10.1001/jama.286.2.196 · Cited by 215 · see citing works

Persistence of Wild-Type Virus and Lack of Temporal Structure in the Latent Reservoir for Human Immunodeficiency Virus Type 1 in Pediatric Patients with Extensive Antiretroviral Exposure

Ruff, C. T., Ray, S. C., Kwon, P., Zinn, R. L., Pendleton, A. R., Hutton, N., Ashworth, R. G., Gange, S. J., Quinn, T. C., Siliciano, R. F., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.18.9481-9492.2002 · Cited by 128 · see citing works

The end of AIDS: HIV infection as a chronic disease

Deeks, S. G., Lewin, S. R., & Havlir, D. V. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61809-7 · Cited by 2,081 · see citing works

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

Chomont, N., Far, M. E., Ancuța, P., Trautmann, L., Procopio, F. A., Yassine‐Diab, B., Boucher, G., Boulassel, M., Ghattas, G., Brenchley, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1972 · Cited by 1,709 · see citing works

Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure

Ho, Y.-C., Shan, L., Hosmane, N. N., Wang, J., Laskey, S. B., Rosenbloom, D. I. S., Lai, J., Blankson, J. N., Siliciano, J. D., & Siliciano, R. F. (2013) · Cell · doi:10.1016/j.cell.2013.09.020 · Cited by 1,405 · see citing works

Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes

Huang, J., Wang, F., Argyris, E. G., Chen, K., Liang, Z., Tian, H., Huang, W., Squires, K., Verlinghieri, G., & Zhang, H. (2007) · Nature Medicine · doi:10.1038/nm1639 · Cited by 766 · see citing works

Defective proviruses rapidly accumulate during acute HIV-1 infection

Bruner, K. M., Murray, A. J., Pollack, R. A., Soliman, M. G., Laskey, S. B., Capoferri, A. A., Lai, J., Strain, M. C., Lada, S. M., Hoh, R., et al. (2016) · Nature Medicine · doi:10.1038/nm.4156 · Cited by 737 · see citing works

Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation

Shan, L., Deng, K., Shroff, N. S., Durand, C. M., Rabi, S. A., Yang, H., Zhang, H., Margolick, J. B., Blankson, J. N., & Siliciano, R. F. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.014 · Cited by 707 · see citing works

Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection

Wagner, T. A., McLaughlin, S., Garg, K., Cheung, C. Y. K., Larsen, B. B., Styrchak, S., Huang, H. C., Edlefsen, P. T., Mullins, J. I., & Frenkel, L. M. (2014) · Science · doi:10.1126/science.1256304 · Cited by 677 · see citing works

HIV infection

Deeks, S. G., Overbaugh, J. M., Phillips, A. N., & Buchbinder, S. P. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.35 · Cited by 657 · see citing works

Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy

Palmer, S., Maldarelli, F. M., Wiegand, A. P., Bernstein, B. M., Hanna, G. J., Brun, S. C., Kempf, D. J., Mellors, J. W., Coffin, J. M., & King, M. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800050105 · Cited by 636 · see citing works

Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production

Perreau, M., Savoye, A.-L., Crignis, E. D., Corpataux, J.-M., Cubas, R. A., Haddad, E. K., de Leval, L., Graziosi, C., & Pantaleo, G. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20121932 · Cited by 632 · see citing works

Shock and kill

Deeks, S. G. (2012) · Nature · doi:10.1038/487439a · Cited by 606 · see citing works

Persistence of HIV in Gut‐Associated Lymphoid Tissue despite Long‐Term Antiretroviral Therapy

Chun, T., Nickle, D. C., Justement, J. S., Meyers, J. H., Roby, G. A., Hallahan, C. W., Kottilil, S., Moir, S. L., Mican, J. M., Mullins, J. I., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/527324 · Cited by 569 · see citing works

Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies

Eriksson, S., Graf, E. H., Dahl, V., Strain, M. C., Yukl, S. A., Lysenko, E. S., Bosch, R. J., Lai, J., Chioma, S., Emad, F., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003174 · Cited by 561 · see citing works

Towards an HIV cure: a global scientific strategy

The International AIDS Society Scientific Working Group on HIV Cure (2012) · Nature reviews. Immunology · doi:10.1038/nri3262 · Cited by 553 · see citing works

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

Lehrman, G. K., Hogue, I. B., Palmer, S., Jennings, C., Spina, C. A., Wiegand, A. P., LANDAY, A. L., Coombs, R. W., Richman, D. D., Mellors, J. W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67098-5 · Cited by 511 · see citing works

Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations

Deng, K., Pertea, M., Rongvaux, A., Wang, L., Durand, C. M., Ghiaur, G., Lai, J., McHugh, H., Hao, H., Zhang, H., et al. (2015) · Nature · doi:10.1038/nature14053 · Cited by 499 · see citing works

New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo

Bullen, C. K., Laird, G. M., Durand, C. M., Siliciano, J. D., & Siliciano, R. F. (2014) · Nature Medicine · doi:10.1038/nm.3489 · Cited by 487 · see citing works

Redefining the Viral Reservoirs that Prevent HIV-1 Eradication

Eisele, E., & Siliciano, R. F. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.010 · Cited by 474 · see citing works

Pathogenic Mechanisms of HIV Disease

Moir, S. L., Chun, T., & Fauci, A. S. (2011) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130254 · Cited by 468 · see citing works

PD-1+ and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals

Banga, R., Procopio, F. A., Noto, A., Pollakis, G., Cavassini, M. L., Ohmiti, K., Corpataux, J.-M., de Leval, L., Pantaleo, G., & Perreau, M. (2016) · Nature Medicine · doi:10.1038/nm.4113 · Cited by 466 · see citing works

Antiretroviral therapy and management of HIV infection

Volberding, P. A., & Deeks, S. G. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60676-9 · Cited by 448 · see citing works

Immune activation and HIV persistence: implications for curative approaches to HIV infection

Klatt, N. R., Chomont, N., Douek, D. C., & Deeks, S. G. (2013) · Immunological Reviews · doi:10.1111/imr.12065 · Cited by 439 · see citing works

Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy

Dinoso, J. B., Kim, S. Y., Wiegand, A. P., Palmer, S., Gange, S. J., Cranmer, L. M., O'Shea, A., Callender, M., Spivak, A. M., Brennan, T. P., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903107106 · Cited by 439 · see citing works

NF‐κB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation

Williams, S. A., Chen, L., Kwon, H., Ruiz-Jarabo, C. M., Verdin, E. M., & Greene, W. C. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600900 · Cited by 428 · see citing works

Residual Human Immunodeficiency Virus Type 1 Viremia in Some Patients on Antiretroviral Therapy Is Dominated by a Small Number of Invariant Clones Rarely Found in Circulating CD4 + T Cells

Bailey, J. R., Sedaghat, A. R., Kieffer, T. L., Brennan, T. P., Lee, P. K., Wind‐Rotolo, M., Haggerty, C. M., Kamireddi, A. R., Liu‐Chittenden, Y., Lee, J., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00591-06 · Cited by 417 · see citing works

Getting the “Kill” into “Shock and Kill”: Strategies to Eliminate Latent HIV

Kim, Y., Anderson, J. L., & Lewin, S. R. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2017.12.004 · Cited by 412 · see citing works

Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies

Crooks, A. M., Bateson, R., Cope, A. B., Dahl, N., Griggs, M. K., Kuruc, J. D., Gay, C. L., Eron, J. J., Margolis, D. M., Bosch, R. J., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv218 · Cited by 399 · see citing works

Ex vivo analysis identifies effective HIV-1 latency–reversing drug combinations

Laird, G. M., Bullen, C. K., Rosenbloom, D. I. S., Martin, A. R., Hill, A. L., Durand, C. M., Siliciano, J. D., & Siliciano, R. F. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80142 · Cited by 393 · see citing works

Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription

Bisgrove, D. A., Mahmoudi, T., Henklein, P., & Verdin, E. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705053104 · Cited by 386 · see citing works

Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice

Halper-Stromberg, A., Lu, C.-L., Klein, F., Horwitz, J. A., Bournazos, S., Nogueira, L., Eisenreich, T., Liu, C., Gazumyan, A., Schaefer, U., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.043 · Cited by 378 · see citing works

Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics

Hosmane, N. N., Kwon, K. J., Bruner, K. M., Capoferri, A. A., Beg, S. A., Rosenbloom, D. I. S., Keele, B. F., Ho, Y., Siliciano, J. D., & Siliciano, R. F. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20170193 · Cited by 373 · see citing works

Defective HIV-1 proviruses are expressed and can Be recognized by cytotoxic T lymphocytes, which shape the proviral landscape

Pollack, R. A., Jones, R. B., Pertea, M., Bruner, K. M., Martin, A. R., Thomas, A. S., Capoferri, A. A., Beg, S. A., Huang, S.-H., Karandish, S., et al. (2017) · Cell Host &amp; Microbe · doi:10.1016/j.chom.2017.03.008 · Cited by 370 · see citing works

Predictors of disease progression in HIV infection: a review

Langford, S. E., Ananworanich, J., & Cooper, D. A. (2007) · AIDS Research and Therapy · doi:10.1186/1742-6405-4-11 · Cited by 336 · see citing works

HIV-1 transcription and latency: an update

Lint, C. M. V., Bouchat, S., & Marcello, A. (2013) · Retrovirology · doi:10.1186/1742-4690-10-67 · Cited by 336 · see citing works

ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia

Maldarelli, F. M., Palmer, S., King, M. S., Wiegand, A. P., Polis, M. A., Mican, J. M., Kovacs, J. A., Davey, R. T., Rock-Kress, D., Dewar, R. L., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030046 · Cited by 333 · see citing works

Targeting the Latent Reservoir for HIV-1

Sengupta, S., & Siliciano, R. F. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.030 · Cited by 333 · see citing works

HIV latency in isolated patient CD4 + T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing

Yukl, S. A., Kaiser, P. D., Kim, P., Telwatte, S., Joshi, S. K., Vu, M., Lampiris, H. W., & Wong, J. K. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aap9927 · Cited by 332 · see citing works

Effect of Treatment, during Primary Infection, on Establishment and Clearance of Cellular Reservoirs of HIV-1

Strain, M. C., Little, S. J., Daar, E. S., Havlir, D. V., Günthard, H. F., Lam, R. Y., Daly, O. A., Nguyen, J., Ignacio, C. C., Spina, C. A., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428777 · Cited by 329 · see citing works

Resting CD4+T Cells from Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Individuals Carry Integrated HIV-1 Genomes within Actively Transcribed Host Genes

Han, Y., Lassen, K. G., Monie, D., Sedaghat, A. R., Shimoji, S., Liu, X., Pierson, T. C., Margolick, J. B., Siliciano, R. F., & Siliciano, J. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6122-6133.2004 · Cited by 328 · see citing works

Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing

Kaminski, R., Chen, Y., Fischer, T., Tedaldi, E., Napoli, A., Zhang, Y., Karn, J., Hu, W., & Khalili, K. (2016) · Scientific Reports · doi:10.1038/srep22555 · Cited by 320 · see citing works

An Integrated Overview of HIV-1 Latency

Ruelas, D. S., & Greene, W. C. (2013) · Cell · doi:10.1016/j.cell.2013.09.044 · Cited by 317 · see citing works

Prostratin Antagonizes HIV Latency by Activating NF-κB

Williams, S. A., Chen, L., Kwon, H., Fenard, D., Bisgrove, D. A., Verdin, E. M., & Greene, W. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402124200 · Cited by 315 · see citing works

Hepatitis C virus resistance to protease inhibitors

Halfon, P., & Locarnini, S. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.01.011 · Cited by 306 · see citing works

International Journal of Collaborative Research on Internal Medicine & Public Health

Valdivia, J. R. M. (2021) · Journal of Womens Health Issues and Care · Cited by 300 · see citing works

HIV-1 DNA predicts disease progression and post-treatment virological control

Williams, J. P., Hurst, J. M., Stöhr, W., Robinson, N., Brown, H. J., Fisher, M., Loes, S. K., Cooper, D. A., Schechter, M., Tambussi, G., et al. (2014) · eLife · doi:10.7554/elife.03821 · Cited by 293 · see citing works

Challenges in Detecting HIV Persistence during Potentially Curative Interventions: A Study of the Berlin Patient

Yukl, S. A., Boritz, E., Busch, M. P., Bentsen, C. G., Chun, T., Douek, D. C., Eisele, E. E., Haase, A. T., Ho, Y., Hütter, G., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003347 · Cited by 292 · see citing works

Isolation and Characterization of Replication-Competent Human Immunodeficiency Virus Type 1 from a Subset of Elite Suppressors

Blankson, J. N., Bailey, J. R., Thayil, S. M., Yang, H., Lassen, K. G., Lai, J., Gandhi, S. K., Siliciano, J. D., Williams, T. M., & Siliciano, R. F. (2006) · Journal of Virology · doi:10.1128/jvi.02165-06 · Cited by 282 · see citing works

Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs

Coiras, M., López‐Huertas, M. R., Pérez‐Olmeda, M., & Alcamı́, J. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2223 · Cited by 281 · see citing works

Epigenetic Silencing of HIV-1 by the Histone H3 Lysine 27 Methyltransferase Enhancer of Zeste 2

Friedman, J. H., Cho, W.-K., Chu, C. K., Keedy, K. S., Archin, N. M., Margolis, D. M., & Karn, J. (2011) · Journal of Virology · doi:10.1128/jvi.00836-11 · Cited by 280 · see citing works

Eradicating HIV-1 infection: seeking to clear a persistent pathogen

Archin, N. M., Sung, J., Garrido, C., Soriano-Sarabia, N., & Margolis, D. M. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3352 · Cited by 278 · see citing works

Current status and challenges of antiretroviral research and therapy

Esté, J. A., & Cihlář, T. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.10.007 · Cited by 277 · see citing works

Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption

Rothenberger, M. K., Keele, B. F., Wietgrefe, S. W., Fletcher, C. V., Beilman, G. J., Chipman, J. G., Khoruts, A., Estes, J. D., Anderson, J. L., Callisto, S. P., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414926112 · Cited by 276 · see citing works

HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir

Chun, T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26197 · Cited by 276 · see citing works

Histone Deacetylase Inhibitor Romidepsin Induces HIV Expression in CD4 T Cells from Patients on Suppressive Antiretroviral Therapy at Concentrations Achieved by Clinical Dosing

Wei, D. G., Chiang, V., Fyne, E., Balakrishnan, M., Barnes, T. L., Graupe, M., Hesselgesser, J., Irrinki, A., Murry, J. P., Stepan, G. J., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004071 · Cited by 272 · see citing works

Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1

Hill, A. L., Rosenbloom, D. I. S., Fu, F., Nowak, M. A., & Siliciano, R. F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406663111 · Cited by 262 · see citing works

Long-Term Reduction in Peripheral Blood HIV Type 1 Reservoirs Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation

Henrich, T. J., Hu, Z., Li, J. Z., Sciaranghella, G., Busch, M. P., Keating, S. M., Gallien, S., Lin, N., Giguel, F. F., LaVoie, L. A., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit086 · Cited by 259 · see citing works

A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals

Procopio, F. A., Fromentin, R., Kulpa, D. A., Brehm, J. H., Bebin-Blackwell, A.-G., Strain, M. C., Richman, D. D., O’Doherty, U., Palmer, S., Hecht, F. M., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.06.019 · Cited by 255 · see citing works

Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation

Yang, H., Xing, S., Shan, L., O’Connell, K., Dinoso, J. B., Shen, A., Zhou, Y., Shrum, C. K., Han, Y., Liu, J. O., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39199 · Cited by 255 · see citing works

Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals

Bar‐On, Y., Gruell, H., Schoofs, T., Pai, J. A., Nogueira, L., Butler, A. L., Millard, K. G., Lehmann, C., Suárez, I., Oliveira, T. Y., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0186-4 · Cited by 254 · see citing works

Coaxing HIV-1 from resting CD4 T cells

Ylisastigui, L., Archin, N. M., Lehrman, G. K., Bosch, R. J., & Margolis, D. M. (2004) · AIDS · doi:10.1097/00002030-200405210-00003 · Cited by 252 · see citing works

Cell-Based Measures of Viral Persistence Are Associated With Immune Activation and Programmed Cell Death Protein 1 (PD-1)–Expressing CD4+ T cells

Hatano, H., Jain, V., Hunt, P. W., Lee, T., Sinclair, E., Do, T., Hoh, R., Martin, J. N., McCune, J. M., Hecht, F. M., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis630 · Cited by 250 · see citing works

Persistence of Transmitted Drug Resistance among Subjects with Primary Human Immunodeficiency Virus Infection

Little, S. J., Frost, S. D. W., Wong, J. K., Smith, D. M., Pond, S. L. K., Ignacio, C. C., Parkin, N. T., Petropoulos, C. J., & Richman, D. D. (2008) · Journal of Virology · doi:10.1128/jvi.02579-07 · Cited by 250 · see citing works

HIV persists throughout deep tissues with repopulation from multiple anatomical sources

Chaillon, A., Gianella, S., Dellicour, S., Rawlings, S. A., Schlub, T. E., De Oliveira, M. F., Ignacio, C., Porrachia, M., Vrancken, B., & Smith, D. M. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134815 · Cited by 250 · see citing works

IL-7 is a potent and proviral strain–specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART

Wang, F., Xu, Y., Sullivan, J., Souder, E., Argyris, E. G., Acheampong, E. A., Fisher, J., Sierra, M., Thomson, M. M., Nájera, R., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522574 · Cited by 248 · see citing works

Modeling HIV persistence, the latent reservoir, and viral blips

Rong, L., & Perelson, A. S. (2009) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2009.06.011 · Cited by 245 · see citing works

HIV interactions with monocytes and dendritic cells: viral latency and reservoirs

Coleman, C. M., & Wu, L. J. (2009) · Retrovirology · doi:10.1186/1742-4690-6-51 · Cited by 239 · see citing works

HIV reservoirs as obstacles and opportunities for an HIV cure

Chun, T., Moir, S. L., & Fauci, A. S. (2015) · Nature Immunology · doi:10.1038/ni.3152 · Cited by 238 · see citing works

Rapid Quantification of the Latent Reservoir for HIV-1 Using a Viral Outgrowth Assay

Laird, G. M., Eisele, E. E., Rabi, S. A., Lai, J., Chioma, S., Blankson, J. N., Siliciano, J. D., & Siliciano, R. F. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003398 · Cited by 237 · see citing works

Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir

Bui, J. K., Sobolewski, M. D., Keele, B. F., Spindler, J., Musick, A., Wiegand, A. P., Luke, B. T., Shao, W., Hughes, S. H., Coffin, J. M., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006283 · Cited by 237 · see citing works

Latency reversal and viral clearance to cure HIV-1

Margolis, D. M., García, J. V., Hazuda, D. J., & Haynes, B. F. (2016) · Science · doi:10.1126/science.aaf6517 · Cited by 236 · see citing works

The multifactorial nature of HIV-1 latency

Lassen, K. G., Han, Y., Zhou, Y., Siliciano, J. D., & Siliciano, R. F. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.09.006 · Cited by 233 · see citing works

Quantification of HIV-1 latency reversal in resting CD4 + T cells from patients on suppressive antiretroviral therapy

Cillo, A. R., Sobolewski, M. D., Bosch, R. J., Fyne, E., Piatak, M., Coffin, J. M., & Mellors, J. W. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402873111 · Cited by 231 · see citing works

The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency

Mousseau, G., Kessing, C. F., Fromentin, R., Trautmann, L., Chomont, N., & Valente, S. T. (2015) · mBio · doi:10.1128/mbio.00465-15 · Cited by 229 · see citing works

Modeling Latently Infected Cell Activation: Viral and Latent Reservoir Persistence, and Viral Blips in HIV-infected Patients on Potent Therapy

Rong, L., & Perelson, A. S. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000533 · Cited by 229 · see citing works

CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T cells to HIV-1 infection: a novel model of HIV-1 latency

Saleh, S. M., Solomon, A. E., Wightman, F., Xhilaga, M., Cameron, P. U., & Lewin, S. R. (2007) · Blood · doi:10.1182/blood-2007-06-097907 · Cited by 228 · see citing works

Post-treatment control of HIV infection

Conway, J. M., & Perelson, A. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419162112 · Cited by 227 · see citing works

Transcriptional control of HIV latency: Cellular signaling pathways, epigenetics, happenstance and the hope for a cure

Mbonye, U. R., & Karn, J. (2014) · Virology · doi:10.1016/j.virol.2014.02.008 · Cited by 226 · see citing works

Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection

Pardons, M., Baxter, A. E., Massanella, M., Pagliuzza, A., Fromentin, R., Dufour, C., Leyre, L., Routy, J., Kaufmann, D., & Chomont, N. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007619 · Cited by 223 · see citing works

Differential decay of intact and defective proviral DNA in HIV-1–infected individuals on suppressive antiretroviral therapy

Peluso, M. J., Bacchetti, P., Ritter, K. D., Beg, S. A., Lai, J., Martin, J. N., Hunt, P. W., Henrich, T. J., Siliciano, J. D., Siliciano, R. F., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.132997 · Cited by 223 · see citing works

HLA Class I-Restricted T-Cell Responses May Contribute to the Control of Human Immunodeficiency Virus Infection, but Such Responses Are Not Always Necessary for Long-Term Virus Control

Emu, B., Sinclair, E., Hatano, H., Ferre, A. L., Shacklett, B. L., Martin, J. N., McCune, J. M., & Deeks, S. G. (2008) · Journal of Virology · doi:10.1128/jvi.02176-07 · Cited by 222 · see citing works

Spirodiketopiperazine-Based CCR5 Inhibitor Which Preserves CC-Chemokine/CCR5 Interactions and Exerts Potent Activity against R5 Human Immunodeficiency Virus Type 1 In Vitro

Maeda, K., Nakata, H., Koh, Y., Miyakawa, T., Ogata, H., Takaoka, Y., Shibayama, S., Sagawa, K., Fukushima, D., Moravek, J., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.16.8654-8662.2004 · Cited by 221 · see citing works

Immediate antiviral therapy appears to restrict resting CD4 + cell HIV-1 infection without accelerating the decay of latent infection

Archin, N. M., Vaidya, N. K., Kuruc, J. D., Liberty, A. L., Wiegand, A. P., Kearney, M. F., Cohen, M. S., Coffin, J. M., Bosch, R. J., Gay, C. L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120248109 · Cited by 220 · see citing works

Cross-Clade Ultrasensitive PCR-Based Assays To Measure HIV Persistence in Large-Cohort Studies

Vandergeeten, C., Fromentin, R., Merlini, E., Lawani, M. B., DaFonseca, S., Bakeman, W., McNulty, A. M., Ramgopal, M. N., Michael, N. L., Kim, J. H., et al. (2014) · Journal of Virology · doi:10.1128/jvi.00609-14 · Cited by 220 · see citing works

Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane

Wang, Z., Gurule, E., Brennan, T. P., Gerold, J. M., Kwon, K. J., Hosmane, N. N., Kumar, M. R., Beg, S. A., Capoferri, A. A., Ray, S. C., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720665115 · Cited by 217 · see citing works

Orientation-Dependent Regulation of Integrated HIV-1 Expression by Host Gene Transcriptional Readthrough

Han, Y., Lin, Y. B., An, W., Xu, J., Yang, H., O’Connell, K. A., Dordai, D. I., Boeke, J. D., Siliciano, J. D., & Siliciano, R. F. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.06.008 · Cited by 214 · see citing works

HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study

Henrich, T. J., Hatano, H., Bacon, O., Hogan, L. E., Rutishauser, R. L., Hill, A. L., Kearney, M. F., Anderson, E. M., Buchbinder, S., Cohen, S. E., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002417 · Cited by 214 · see citing works

Nuclear Retention of Multiply Spliced HIV-1 RNA in Resting CD4+ T Cells

Lassen, K. G., Ramyar, K. X., Bailey, J. R., Zhou, Y., & Siliciano, R. F. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020068 · Cited by 213 · see citing works

HIV Latency Is Established Directly and Early in Both Resting and Activated Primary CD4 T Cells

Chávez, L., Calvanese, V., & Verdin, E. M. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004955 · Cited by 211 · see citing works

Experimental approaches to the study of HIV-1 latency

Han, Y., Wind‐Rotolo, M., Yang, H., Siliciano, J. D., & Siliciano, R. F. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1580 · Cited by 207 · see citing works

Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications

Avettand-Fènoël, V., Hocqueloux, L., Ghosn, J., Chéret, A., Frange, P., Mélard, A., Viard, J., & Rouzioux, C. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00015-16 · Cited by 207 · see citing works

PD-1 blockade potentiates HIV latency reversal ex vivo in CD4+ T cells from ART-suppressed individuals

Fromentin, R., DaFonseca, S., Costiniuk, C. T., Far, M. E., Procopio, F. A., Hecht, F. M., Hoh, R., Deeks, S. G., Hazuda, D. J., Lewin, S. R., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08798-7 · Cited by 207 · see citing works

Prolonged viral suppression with anti-HIV-1 antibody therapy

Gaebler, C., Nogueira, L., Stoffel, E., Oliveira, T. Y., Breton, G., Millard, K. G., Turroja, M., Butler, A. L., Ramos, V., Seaman, M. S., et al. (2022) · Nature · doi:10.1038/s41586-022-04597-1 · Cited by 204 · see citing works

A Pilot Study Assessing the Safety and Latency-Reversing Activity of Disulfiram in HIV-1-Infected Adults on Antiretroviral Therapy

Spivak, A. M., Andrade, A. S., Eisele, E. E., Hoh, R., Bacchetti, P., Bumpus, N. N., Emad, F., Buckheit, R. W., McCance‐Katz, E. F., Lai, J., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit813 · Cited by 199 · see citing works

Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection

Shen, L., & Siliciano, R. F. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.05.033 · Cited by 198 · see citing works

The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation

Abrahams, M.-R., Joseph, S. B., Garrett, N., Tyers, L., Moeser, M., Archin, N., Council, O. D., Matten, D., Zhou, S., Doolabh, D., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw5589 · Cited by 196 · see citing works

Decay of the HIV Reservoir in Patients Receiving Antiretroviral Therapy for Extended Periods: Implications for Eradication of Virus

Chun, T., Justement, J. S., Moir, S. L., Hallahan, C. W., Maenza, J. R., Mullins, J. I., Collier, A. C., Corey, L., & Fauci, A. S. (2007) · The Journal of Infectious Diseases · doi:10.1086/518250 · Cited by 195 · see citing works

Disulfiram Reactivates Latent HIV-1 in a Bcl-2-Transduced Primary CD4 + T Cell Model without Inducing Global T Cell Activation

Xing, S., Bullen, C. K., Shroff, N. S., Shan, L., Yang, H., Manucci, J. L., Bhat, S., Zhang, H., Margolick, J. B., Quinn, T. C., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02033-10 · Cited by 195 · see citing works

Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation

Jiang, G., Mendes, É. A., Kaiser, P. D., Wong, D. P., Tang, Y., Cai, I., Fenton, A. N., MELCHER, G. P., Hildreth, J. E. K., Thompson, G. R., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005066 · Cited by 190 · see citing works

Towards an HIV-1 cure: measuring the latent reservoir

Bruner, K. M., Hosmane, N. N., & Siliciano, R. F. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.01.013 · Cited by 184 · see citing works

Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy

Xiao, Q., Guo, D., & Chen, S. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00069 · Cited by 184 · see citing works

The Challenge of Viral Reservoirs in HIV-1 Infection

Blankson, J. N., Persaud, D., & Siliciano, R. F. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104024 · Cited by 623 · see citing works

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., et al. (1997) · Science · doi:10.1126/science.278.5341.1295 · Cited by 3,098 · see citing works

Latency and viral persistence in HIV-1 infection

Siliciano, J. D., & Siliciano, R. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11246 · Cited by 52 · see citing works

The Remarkable Stability of the Latent Reservoir for HIV-1 in Resting Memory CD4+T Cells

Siliciano, J. D., & Siliciano, R. F. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv219 · Cited by 73 · see citing works

Oncotarget19920www.impactjournals.com/oncotarget

Seu, L., & Kutsch, O. (2016)